Drug Trial Radar · NCT00025363
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
Last checked: Nov 19, 2026Latest source record: Jan 17, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Nov 2001
Primary completion
Oct 2007
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Randomized phase II trial to compare the effectiveness of different combination chemotherapy regimens in treating children who have rhabdomyosarcoma. Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells
Conditions
- Alveolar Childhood Rhabdomyosarcoma
- Embryonal Childhood Rhabdomyosarcoma
- Embryonal-botryoid Childhood Rhabdomyosarcoma
- Previously Treated Childhood Rhabdomyosarcoma
- Recurrent Childhood Rhabdomyosarcoma
Interventions
vincristine sulfateDrug
Given IV
irinotecan hydrochlorideDrug
Given IV
cyclophosphamideDrug
Given IV
doxorubicin hydrochlorideDrug
Given IV
ifosfamideDrug
Given IV
etoposideDrug
Given IV
tirapazamineDrug
Given IV
filgrastimBiological
Given SC
sargramostimBiological
Given SC
pharmacological studyOther
Correlative studies
pharmacogenomic studiesOther
Correlative studies
laboratory biomarker analysisOther
Correlative studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Response at week 6 of investigational window therapy (unfavorable risk patients)Time frame: At week 6
- Incidence of DLT when tirapazamine is given in combination with cyclophosphamide and doxorubicin, graded according to the NCI CTC v 2.0Time frame: Up to 6 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Children's Oncology Group
Arcadia, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.